# Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology

> **NCT00629720** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 29 (actual)

## Conditions studied

- Urinary Bladder Neurogenic

## Interventions

- **DRUG:** alfuzosin (SL770499)

## Key facts

- **NCT ID:** NCT00629720
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2009-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629720, "Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00629720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*